11/26
08:19 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $55.00 price target on the stock.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $55.00 price target on the stock.
11/26
08:19 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $55.00 price target on the stock.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) is now covered by analysts at Evercore ISI. They set an "outperform" rating and a $55.00 price target on the stock.
11/26
08:13 am
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
11/13
08:10 am
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
11/13
08:10 am
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
10/30
03:59 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) was upgraded by analysts at Citigroup Inc. to a "strong-buy" rating.
10/28
12:38 pm
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
10/28
12:38 pm
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
10/28
11:29 am
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
10/28
11:29 am
zbio
Rating for ZBIO
Low
Report
Rating for ZBIO
10/28
10:59 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at Citigroup Inc..
10/27
11:08 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $40.00.
Medium
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $40.00.
10/27
11:08 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $40.00.
Medium
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "outperform" rating reaffirmed by analysts at Wedbush. They now have a $45.00 price target on the stock, up previously from $40.00.
10/27
03:59 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/27
03:59 pm
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
Low
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "overweight" rating reaffirmed by analysts at Morgan Stanley.
10/9
09:02 am
zbio
Rating for ZBIO
High
Report
Rating for ZBIO
10/9
09:02 am
zbio
Rating for ZBIO
High
Report
Rating for ZBIO
10/9
08:07 am
zbio
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.
High
Report
Zenas BioPharma (NASDAQ:ZBIO) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $30.00 price target on the stock.